Send the following on WhatsApp
Continue to ChatUmbralisib and potential increased risk of death [under USFDA investigation]: Need for consistent evaluation of benefits & risks https://publicsafetyandvigilance.com/2022/02/umbralisib-and-potential-increased-risk-of-death-under-usfda-investigation-need-for-consistent-evaluation-of-benefits-risks/